Status and phase
Conditions
Treatments
About
The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetic (PK) of UCB0022 and food effect.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Not a woman of childbearing potential (WOCBP) as defined in the protocol OR A WOCBP who agrees to follow the contraceptive guidance in the protocol during the Treatment Period and for at least 90 days after the last dose of study treatment
Part C only:
Exclusion criteria
Part C only:
Primary purpose
Allocation
Interventional model
Masking
100 participants in 6 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal